The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ives Jeffrey L. since 2019.
This trader's CIK number is 1614096.
At the time of last reporting, Ives Jeffrey L. was the Director of Acumen Pharmaceuticals, Inc.. (stock ticker symbol ABOS).
Also see all insider trading activities at Acumen Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | CARA | 0 | $0 | 3,600 | $32,580 | 0 | $0 |
2021 | CARA | 0 | $0 | 10,700 | $164,093 | 0 | $0 |
2020 | CARA | 0 | $0 | 13,500 | $216,900 | 13,500 | $134,190 |
2019 | CARA | 0 | $0 | 15,000 | $332,548 | 15,000 | $79,800 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | ABOS | 0 | $0 | 41,949 | $275,604 | 41,949 | $40,061 |
1. Cara Therapeutics, Inc. (CARA)
2. Acumen Pharmaceuticals, Inc. (ABOS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-07-15 | CARA | Sale | 3,600 | 9.05 | 32,580 |
2021-11-12 | CARA | Sale | 8,180 | 16.04 | 131,207 |
2021-06-07 | CARA | Sale | 2,520 | 13.05 | 32,886 |
2020-06-01 | CARA | Option Ex | 1,000 | 9.94 | 9,940 |
2020-06-01 | CARA | Sale | 1,000 | 16.00 | 16,000 |
2020-05-12 | CARA | Sale | 2,500 | 16.00 | 40,000 |
2020-05-12 | CARA | Option Ex | 2,500 | 9.94 | 24,850 |
2020-04-21 | CARA | Option Ex | 2,500 | 9.94 | 24,850 |
2020-04-21 | CARA | Sale | 2,500 | 16.00 | 40,000 |
2020-03-04 | CARA | Option Ex | 2,500 | 9.94 | 24,850 |
2020-03-04 | CARA | Sale | 2,500 | 16.00 | 40,000 |
2020-02-03 | CARA | Option Ex | 2,500 | 9.94 | 24,850 |
2020-02-03 | CARA | Sale | 2,500 | 16.23 | 40,575 |
2020-01-02 | CARA | Sale | 2,500 | 16.13 | 40,325 |
2020-01-02 | CARA | Option Ex | 2,500 | 9.94 | 24,850 |
2019-12-02 | CARA | Option Ex | 2,500 | 5.32 | 13,300 |
2019-12-02 | CARA | Sale | 2,500 | 25.83 | 64,574 |
2019-11-01 | CARA | Sale | 2,500 | 20.68 | 51,700 |
2019-11-01 | CARA | Option Ex | 2,500 | 5.32 | 13,300 |
2019-10-01 | CARA | Sale | 2,500 | 18.21 | 45,525 |
2019-10-01 | CARA | Option Ex | 2,500 | 5.32 | 13,300 |
2019-09-03 | CARA | Option Ex | 2,500 | 5.32 | 13,300 |
2019-09-03 | CARA | Sale | 2,500 | 23.31 | 58,275 |
2019-08-01 | CARA | Option Ex | 2,500 | 5.32 | 13,300 |
2019-08-01 | CARA | Sale | 2,500 | 23.24 | 58,099 |
2019-07-01 | CARA | Option Ex | 2,500 | 5.32 | 13,300 |
2019-07-01 | CARA | Sale | 2,500 | 21.75 | 54,375 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-08-17 | ABOS | Option Ex | 41,949 | .95 | 40,061 |
2023-08-17 | ABOS | Sale | 41,949 | 6.57 | 275,604 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ives Jeffrey L. (Director of Acumen Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.